Literature DB >> 6601053

Recognition of Db and Kb gene products by influenza-specific cytotoxic T cells.

A R Townsend, P M Taylor, A L Mellor, B A Askonas.   

Abstract

A series of 16 H-2b-restricted, A influenza virus-specific cytotoxic T-cell clones are described and characterized. One is Kb restricted, the others Db restricted. The factors governing Kb or Db restriction patterns seen in the mixed populations from which clones are derived are investigated. The Kb-restricted clone does not recognize Kb mutant bml and influenza and all 15 Db-restricted clones do not recognize Db mutant bml4 and A influenza virus; these results are discussed in the light of findings in a variety of other viral systems. Representative Kb- and Db-restricted clones were used to assess the functional properties of cloned cosmids containing either Kb or Db genes expressed in transformed L-cells (k haplotype). The expression products of both cosmids functioned efficiently as mutually exclusive restriction elements for A influenza virus recognition.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6601053     DOI: 10.1007/bf00364412

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  29 in total

1.  Long term culture of tumour-specific cytotoxic T cells.

Authors:  S Gillis; K A Smith
Journal:  Nature       Date:  1977-07-14       Impact factor: 49.962

2.  Specificities of killing by T lymphocytes generated against syngeneic SV40 transformants: cross-reactivity of the H-2Kbm1 through Kbm4 H-2 mutant alleles in Kb-restricted SV40-specific killing.

Authors:  A C Whitmore; L R Gooding
Journal:  J Immunol       Date:  1981-09       Impact factor: 5.422

3.  H-2 expression by lymphoid cells of different mouse strains: quantitative interaction of H-2 with monoclonal antibodies and their Fab fragments.

Authors:  C J Hackett; B A Askonas
Journal:  Immunology       Date:  1981-02       Impact factor: 7.397

4.  Structure and expression of the human globin genes and murine histocompatibility antigen genes.

Authors:  R A Flavell; F Grosveld; M Busslinger; E de Boer; D Kioussis; A L Mellor; L Golden; E Weiss; J Hurst; H Bud; H Bullman; E Simpson; R James; A R Townsend; P M Taylor; W Schmidt; J Ferluga; L Leben; M Santamaria; G Atfield; H Festenstein
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1983

Review 5.  Biochemistry of the gene products from murine MHC mutants.

Authors:  R Nairn; K Yamaga; S G Nathenson
Journal:  Annu Rev Genet       Date:  1980       Impact factor: 16.830

6.  DNA-mediated transfer of the adenine phosphoribosyltransferase locus into mammalian cells.

Authors:  M Wigler; A Pellicer; S Silverstein; R Axel; G Urlaub; L Chasin
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

7.  Genetic control of the cytolytic T lymphocyte response to influenza viruses: H-2 genes influence the response to H-2Kb plus virus.

Authors:  C S Reiss; M E Dorf; B Benacerraf; S J Burakoff
Journal:  J Immunol       Date:  1982-05       Impact factor: 5.422

8.  Limit-dilution analysis of weak influenza-immune T cell responses associated with H-2Kb and H-2Db.

Authors:  M Allouche; J A Owen; P C Doherty
Journal:  J Immunol       Date:  1982-08       Impact factor: 5.422

9.  A pseudogene homologous to mouse transplantation antigens: transplantation antigens are encoded by eight exons that correlate with protein domains.

Authors:  M Steinmetz; K W Moore; J G Frelinger; B T Sher; F W Shen; E A Boyse; L Hood
Journal:  Cell       Date:  1981-09       Impact factor: 41.582

10.  Heterogeneity and specificity of cloned lines of influenza-virus specific cytotoxic T lymphocytes.

Authors:  T J Braciale; M E Andrew; V L Braciale
Journal:  J Exp Med       Date:  1981-04-01       Impact factor: 14.307

View more
  11 in total

1.  Respiratory syncytial virus infection in C57BL/6 mice: clearance of virus from the lungs with virus-specific cytotoxic T cells.

Authors:  J L Muñoz; C A McCarthy; M E Clark; C B Hall
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

2.  A cluster of mutations in HLA-A2 alpha 2 helix abolishes peptide recognition by T cells.

Authors:  R J Moots; M Matsui; L Pazmany; A J McMichael; J A Frelinger
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

3.  Control of immune interferon release by cytotoxic T-cell clones specific for influenza.

Authors:  P M Taylor; D C Wraith; B A Askonas
Journal:  Immunology       Date:  1985-04       Impact factor: 7.397

4.  Influenza-specific cytotoxic T-cell recognition is inhibited by peptides unrelated in both sequence and MHC restriction.

Authors:  H C Bodmer; J M Bastin; B A Askonas; A R Townsend
Journal:  Immunology       Date:  1989-02       Impact factor: 7.397

5.  Low responder MHC alleles for Tc recognition of influenza nucleoprotein.

Authors:  P Pala; B A Askonas
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

6.  Cytotoxic T-cell recognition of influenza-infected target cells varies in different H-2k mouse strains.

Authors:  M Stringfellow; D C Wraith; B A Askonas
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

7.  Dk-restricted antiinfluenza cytotoxic T-cell clone loses one of its two alloreactivities.

Authors:  D C Wraith
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

8.  Diversity in the interaction of influenza-A-specific cytotoxic T cells with H-2Kb mutant targets.

Authors:  A R Townsend; P M Taylor; C J Melief; B A Askonas
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

9.  Use of synthetic peptides of influenza nucleoprotein to define epitopes recognized by class I-restricted cytotoxic T lymphocytes.

Authors:  J Bastin; J Rothbard; J Davey; I Jones; A Townsend
Journal:  J Exp Med       Date:  1987-06-01       Impact factor: 14.307

10.  Long-term persistence of activated cytotoxic T lymphocytes after viral infection of the central nervous system.

Authors:  S Hawke; P G Stevenson; S Freeman; C R Bangham
Journal:  J Exp Med       Date:  1998-05-18       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.